Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $3.08 Million - $3.92 Million
-49,600 Reduced 89.53%
5,800 $423,000
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $752,400 - $2.38 Million
34,200 Added 161.32%
55,400 $3.71 Million
Q1 2024

May 13, 2024

SELL
$25.72 - $29.94 $59,156 - $68,862
-2,300 Reduced 9.79%
21,200 $575,000
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $466,710 - $632,855
23,500 New
23,500 $593,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.